Journals / Laparoscopic Endoscopic Surgical Science / 2021 / Cilt: 28 - Sayı: 1

Safety of the concomitant cholecystectomy during laparoscopic sleeve gastrectomy in patients with symptomatic gallstone: A single-center experience

Pages
44–49
Publication Date
2022-09-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: CC during LSG is a safe procedure in patients with symptomatic gallstone, which has an acceptable increase in operation time and does not cause an increase in minor or major complications and prolongation on length of stay

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: There are still controversies in the management of gallstones in patients who are candidate for bariatric surgery.
📊
Key Findings & Data:Materials and Methods: After exclusion and inclusion criteria, a total of 251 patients were included in the study.
💡
Conclusion & Impact:Conclusion: CC during LSG is a safe procedure in patients with symptomatic gallstone, which has an acceptable increase in operation time and does not cause an increase in minor or major complications and prolongation on length of stay
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: There are still controversies in the management of gallstones in patients who are candidate for bariatric surgery. The aim of this study was to evaluate the effect of the concomitant cholecystectomy (CC) during laparoscopic sleeve gastrectomy (LSG) on post-operative short-term complications in patients with symptomatic gallstone. Materials and Methods: After exclusion and inclusion criteria, a total of 251 patients were included in the study. Patients were divided into two study groups as Group A (only LSG, n=214) and Group B (LSG + CC, n=37). Results: Female-to-male ratio was 2/1 in Group A and 8/1 in Group B (p=0.01). The mean age, comorbid disease distributions, length of stay, and initial body mass index were similar in both groups. The differences in the rates of postoperative 30-day minor and major complications in Group A (7.5% and 2.8%, respectively) and Group B (18.9% and 2.7%, respectively) were not significant (p=0.64). CC prolonged the operation time at an average of 15 min (p<0.001). Conclusion: CC during LSG is a safe procedure in patients with symptomatic gallstone, which has an acceptable increase in operation time and does not cause an increase in minor or major complications and prolongation on length of stay

🔖

Cite This Article

Yur, M., Lale, A., Aygen, E., Doğan, O., Kırkıl, C. (2022). Safety of the concomitant cholecystectomy during laparoscopic sleeve gastrectomy in patients with symptomatic gallstone: A single-center experience. Laparoscopic Endoscopic Surgical Science, Cilt: 28 - Sayı: 1, 44–49. https://ajindex.com/articles/423559

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Weinsier RL, Ullmann DO. Gallstone formation and weight loss. Obes Res 1993
  2. 51–6. [CrossRef] 2. Wudel LJ Jr., Wright JK, Debelak JP, Allos TM, Shyr Y, Chapman WC. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: Results of a randomized controlled pilot study. J Surg Res 2002
  3. 50–6. [CrossRef] 3. Talha A, Abdelbaki T, Farouk A, Hasouna E, Azzam E, Shehata G. Cholelithiasis after bariatric surgery, incidence, and prophylaxis: Randomized controlled trial. Surg Endosc 2019
  4. 5331–7. [CrossRef] 4. Morais M, Faria G, Preto J, Costa-Maia J. Gallstones and bariatric surgery: To treat or not to treat? World J Surg 2016
  5. 2904–10. [CrossRef] 5. Chen JH, Tsai MS, Chen CY, Lee HM, Cheng CF, Chiu YT, et al. Bariatric surgery did not increase the risk of gallstone disease in obese patients: A comprehensive cohort study. Obes Surg 2019
  6. 464–73. [CrossRef] 6. Wrzesinski A, Corrêa JM, Fernandes TM, Monteiro LF, Trevisol FS, do Nascimento RR. Complications requiring hospital management after bariatric surgery. Arq Bras Cir Dig 2015
  7. 28 Suppl 1:3–6. [CrossRef] 7. Chang J, Corcelles R, Boules M, Jamal MH, Schauer PR, Kroh MD. Predictive factors of biliary complications after bariatric surgery. Surg Obes Relat Dis 2016
  8. 1706–10. [CrossRef] 8. Şen O, Türkçapar AG, Yerdel MA. Cholelithiasis after sleeve gastrectomy and effectiveness of ursodeoxycholic acid treatment. J Laparoendosc Adv Surg Tech A 2020
  9. 1150– 2. [CrossRef] 9. Magouliotis DE, Tasiopoulou VS, Svokos AA, Svokos KA, Chatedaki C, Sioka E, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: An updated systematic review and meta-analysis. Obes Surg 2017
  10. 3021–30. [CrossRef] 10. Grover BT, Kothari SN. Biliary issues in the bariatric population. Surg Clin North Am 2014
  11. 413–25. [CrossRef] 11. Yardimci S, Coskun M, Demircioglu S, Erdim A, Cingi A. Is concomitant cholecystectomy necessary for asymptomatic cholelithiasis during laparoscopic sleeve gastrectomy? Obes Surg 2018
  12. 469–73. [CrossRef] 12. Li VK, Pulido N, Martinez-Suartez P, Fajnwaks P, Jin HY, Szomstein S, et al. Symptomatic gallstones after sleeve gastrectomy. Surg Endosc 2009
  13. 2488–92. [CrossRef] 13. Wood SG, Kumar SB, Dewey E, Lin MY, Carter JT. Safety of concomitant cholecystectomy with laparoscopic sleeve gastrectomy and gastric bypass: A MBSAQIP analysis. Surg Obes Relat Dis 2019
  14. 864–70. [CrossRef] 14. Coşkun H, Hasbahçeci M, Bozkurt S, Çipe G, Maly